哈药集团三精制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
187
NMPA:187
Drug Approvals
Compound Calcium Gluconate Oral Solution
- Product Name
- 复方葡萄糖酸钙口服溶液
- Approval Number
- 国药准字H20193040
- Approval Date
- Jan 31, 2024
NMPA
Zinc Sulfate Oral Solution
- Product Name
- 硫酸锌口服溶液
- Approval Number
- 国药准字H20184129
- Approval Date
- Sep 13, 2023
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20184128
- Approval Date
- Sep 13, 2023
NMPA
Chlorphenamine Maleate Injection
- Product Name
- 马来酸氯苯那敏注射液
- Approval Number
- 国药准字H23021452
- Approval Date
- Mar 7, 2023
NMPA
Procaine and Adrenaline Injection
- Product Name
- 普鲁卡因肾上腺素注射液
- Approval Number
- 国药准字H23020970
- Approval Date
- Mar 7, 2023
NMPA
Sodium Bicarbonate Injection
- Product Name
- 碳酸氢钠注射液
- Approval Number
- 国药准字H23020972
- Approval Date
- Mar 7, 2023
NMPA
Glucose and Calcium Chloride Iniection
- Product Name
- 葡萄糖氯化钙注射液
- Approval Number
- 国药准字H23022966
- Approval Date
- Mar 7, 2023
NMPA
Calcium Chloride Injection
- Product Name
- 氯化钙注射液
- Approval Number
- 国药准字H23021424
- Approval Date
- Mar 7, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
Clinical Trials
No trials found
News
No news found